| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $85.1M | -9.3% |
| Cost of Revenue | $44.0M | -10.8% |
| Gross Profit | $41.1M | -7.5% |
| R&D Expense | $32.4M | -20.4% |
| SG&A Expense | $45.9M | -3.9% |
| Operating Income | -$86.7M | +22.2% |
| Interest Expense | $848K | +127.3% |
| Pre-tax Income | -$86.8M | +16.7% |
| Income Tax | -$1.2M | -112.1% |
| Net Income | -$85.6M | +17.4% |
| EPS (Basic) | -$4.22 | -696.2% |
| EPS (Diluted) | -$4.22 | -696.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.6M | -54.1% |
| Accounts Receivable | $20.5M | -14.6% |
| Inventory | $22.4M | -16.5% |
| Current Assets | $101.3M | -41.3% |
| Total Assets | $168.9M | -31.9% |
| Current Liabilities | $40.8M | +0.2% |
| Total Liabilities | $82.4M | -4.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.3M | -25.3% |
| Capital Expenditures | $1.4M | -60.3% |
| Investing Cash Flow | -$1.4M | -103.4% |
| Financing Cash Flow | -$1.2M | -122.3% |
| Free Cash Flow | -$62.7M | -19.5% |
| Stockholders' Equity |
| $86.5M |
| -46.5% |